Levin Capital Strategies, L.P. Pa Vmed Inc. Transaction History

Levin Capital Strategies, L.P.

$1.03 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$0.35 - $0.56 $52,605 - $84,168	-150,300 Reduced 50.09%	149,750 $61,000
Q1 2023 Apr 24, 2023	BUY	$0.36 - $0.63 $7,308 - $12,789	20,300 Added 7.26%	300,050 $111,000
Q4 2022 Feb 13, 2023	BUY	$0.41 - $18.6 $53,300 - $2.42 Million	130,000 Added 86.81%	279,750 $134,000
Q3 2022 Nov 08, 2022	SELL	$0.57 - $34.65 $3,173 - $192,931	-5,568 Reduced 3.58%	149,750 $129,000
Q2 2022 Aug 15, 2022	SELL	$0.85 - $1.41 $148,750 - $246,750	-175,000 Reduced 52.98%	155,318 $145,000
Q1 2022 May 02, 2022	BUY	$1.16 - $2.5 $359,600 - $775,000	310,000 Added 1525.74%	330,318 $436,000
Q4 2021 Feb 15, 2022	SELL	$2.46 - $8.74 $28,304 - $100,562	-11,506 Reduced 36.16%	20,318 $50,000
Q3 2021 Nov 10, 2021	SELL	$5.1 - $9.39 $11,097 - $20,432	-2,176 Reduced 6.4%	31,824 $272,000
Q1 2021 May 05, 2021	SELL	$2.01 - $5.55 $140,699 - $388,500	-70,000 Reduced 67.31%	34,000 $151,000
Q4 2020 Feb 16, 2021	SELL	$1.73 - $2.13 $17,300 - $21,300	-10,000 Reduced 8.77%	104,000 $220,000
Q3 2020 Nov 17, 2020	BUY	$1.76 - $2.17 $8,800 - $10,850	5,000 Added 4.59%	114,000 $203,000
Q2 2020 Aug 13, 2020	BUY	$1.75 - $2.65 $87,500 - $132,500	50,000 Added 84.75%	109,000 $230,000
Q1 2020 May 13, 2020	SELL	$1.15 - $3.29 $1,150 - $3,290	-1,000 Reduced 1.67%	59,000 $117,000
Q4 2019 Feb 10, 2020	BUY	$0.84 - $1.2 $42,000 - $60,000	50,000 Added 500.0%	60,000 $72,000
Q3 2019 Nov 14, 2019	SELL	$0.95 - $1.11 $133,950 - $156,510	-141,000 Reduced 93.38%	10,000 $10,000
Q2 2019 Aug 13, 2019	BUY	$1.03 - $1.32 $129,780 - $166,320	126,000 Added 504.0%	151,000 $172,000
Q1 2019 May 13, 2019	BUY	$0.94 - $1.16 $23,500 - $28,999	25,000 New	25,000 $27,000
Q3 2018 Oct 29, 2018	SELL	$1.11 - $1.64 $241,036 - $356,126	-217,150 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$0.89 - $1.77 $130,919 - $260,367	147,100 Added 209.99%	217,150 $206,000
Q1 2018 May 18, 2018	BUY	$1.51 - $3.21 $105,775 - $224,860	70,050 New	70,050 $115,000
Q4 2017 Feb 09, 2018	SELL	$2.18 - $5.7 $24,034 - $62,842	-11,025 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$2.84 - $8.59 $31,311 - $94,704	11,025	11,025 $60,000

Others Institutions Holding PAVM

# of Institutions

Shares Held

2.24M

Call Options Held

Put Options Held

Ayrton Capital LLC Westport, CT

2.24M
Shares

$1.3 Million
25.49% of portfolio

View Full List

About PAVmed Inc.

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $52.8M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

More about PAVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Levin Capital Strategies, L.P. with notifications on news.

Account